Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Health Literacy Among Youth," is focused on improving young people's understanding of health and how it affects their lives. Researchers are looking at the connection between education levels and health outcomes to help reduce inequalities in health among youth. The goal is to create a program that helps students in Danish schools learn more about health and develop better health-related behaviors.
To participate in this study, you need to be between 15 and 25 years old and a student at one of the selected schools. If you agree to take part, you'll need to sign a consent form. Participants can expect to be involved in activities designed to boost their health knowledge and skills. This trial is currently recruiting participants, and everyone, regardless of gender, is welcome to join. It’s a great opportunity to contribute to important research that could help improve health education for young people in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Providing an informed signed consent prior to participation.
- • Student at one of the enrolled schools
- • 15-25 years of age or turns 15 during the project period.
- Exclusion Criteria:
- • Under the age of 15 and does not turn 15 during the project period.
- • above the age of 25 before the project period starts.
About Holbaek Sygehus
Holbæk Sygehus, a leading healthcare institution in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on collaboration and ethical practice, the hospital provides a robust infrastructure for conducting a diverse range of studies across various therapeutic areas. Holbæk Sygehus is committed to fostering a patient-centered approach, ensuring that clinical trials not only contribute to scientific knowledge but also prioritize safety and well-being. Through its experienced research team and state-of-the-art facilities, Holbæk Sygehus plays a pivotal role in the development of new therapies and enhancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Holbaek, Region Sjælland, Denmark
Holbaek, , Denmark
Patients applied
Trial Officials
Vivian Rueskov Poulsen
Principal Investigator
Holbæk Sygehus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported